Cancer glossary
The AC-T regimen for breast cancer: doxorubicin, cyclophosphamide, then a taxane
AC-T is a classic breast cancer chemotherapy regimen: 4 cycles of AC (‘red chemo’), then paclitaxel or docetaxel. How it goes, what dose-dense means and what is checked.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 19 October 2026
In short
AC-T is a two-stage breast cancer chemotherapy regimen. First 4 cycles of AC — doxorubicin (Adriamycin) and Cyclophosphamide — then T, a taxane: paclitaxel or docetaxel.
How it appears in your prescription
- ‘AC × 4 every 3 weeks → paclitaxel weekly × 12’.
- ‘ddAC × 4 → ddP × 4 (every 14 days) + G-CSF’ — dose-dense schedule.
- ‘Paclitaxel + carboplatin → AC + pembrolizumab’ — in triple-negative cancer before surgery.
- In HER2-positive cancer, trastuzumab and pertuzumab are added during the taxane stage.
What it means
According to the US National Cancer Institute, AC-T is used before or after surgery for higher-risk breast cancer — for example, triple-negative or HER2-positive subtypes. Heart function is checked (echocardiogram) before doxorubicin, because the drug has a lifetime cumulative dose limit.
Side effects
On AC: hair loss (almost always), nausea, low neutrophils, mouth sores and red urine for the first day. Longer term, a risk of cardiotoxicity. On the taxane: neuropathy and muscle aches. A temperature of 38 °C (100.4 °F) or higher means contacting your clinic urgently.
Questions to ask your doctor
- Standard or dose-dense schedule — and why?
- How will my heart be checked during and after treatment?
- What should I do about a fever at the weekend?
Sources
- Doxorubicin Hydrochloride — National Cancer Institute
- Cyclophosphamide — National Cancer Institute
- Chemotherapy for Breast Cancer — National Cancer Institute
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
